Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ReciBioPharm Awarded RNA Manufacturing Grant | Contract Pharma

What are you searching for?

Sign in
Breaking News

ReciBioPharm Awarded RNA Manufacturing Grant

Aims to enhance RNA production technologies with the goal of a continuous manufacturing platform and advancement of PAT.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

ReciBioPharm, a division of Recipharm, a CDMO, has been awarded a three-year grant from the Bill & Melinda Gates Foundation to support the global deployment of xRNA Continuous Manufacturing technologies to Low- and Middle-Income Countries with a focus on the development of inline Process Analytical Technologies and predictive analytics software. ReciBioPharm’s platform aims to improve the scalability, quality, and accessibility of RNA-based medicines and will help advance its goal of developing fully integrated, continuous processes.

Vikas Gupta, President of ReciBioPharm, said: “This grant represents a significant milestone in our commitment to advancing RNA manufacturing technologies that meet FDA standards. We are proud to lead this transformative effort, expanding access to RNA-based solutions for underserved regions.”

“Our previously-announced collaboration with MIT has underscored the potential of continuous manufacturing for RNA therapeutics,” added Aaron Cowley, Chief Scientific Officer of ReciBioPharm. “This grant will help to strengthen our role as a pioneer in innovation and support our mission to make lifesaving technologies more accessible.”  

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics